JCRB1346 FLAM-76
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1346 | Cell Name | FLAM-76 |
---|---|---|---|
Profile | Interleukin-6-dependent human myeloma cell line from an agressive nonsecretory plasma cell leukemia. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 77 |
Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
Case history | agressive nonsecretory plasma cell leukemia | Metastasis | |
Tissue Metastasized | Genetics | Hypodiploid chromosome with t(11;14)(q13;q32). | |
Life Span | infinite | Crisis PDL | |
Morphology | plasmacytoid | Character | kappa IgG (nonsecretory), CD38, CD44, and CD54 are positive. |
Classify | tumor | Established by | Kubonishi,I. |
Registered by | Miyoshi,I. | Regulation for Distribution | |
Comment | Year | 2007 | |
Medium | RPMI 1640 medium with 20% fetal bovine serum, IL-6 10ng/mL. | Methods for Passages | dilution suspension culture |
Cell Number on Passage | 1/2 - 1/3 | Race | Japanese |
CO2 Conc. | 5% | Tissue Sampling | |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:1516003 | The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia. Kubonishi I,Seto M,Shimamura T,Enzan H,Miyoshi I Cancer. 1992 Sep 15;70(6):1528-35 |
Images |
---|
LOT Information
Cell No. | JCRB1346 | Cell Name | FLAM-76 |
---|---|---|---|
LOT No. | 04272012 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 20% heat-inactivated fetal bovine serum and 10 ng/mL recombinant human IL-6. | Temperature | 37 C |
Cell Density at Seeding | 2-4 x 10^5 cells/mL. | Methods for Passages | Simple dilution (suspension culture). Split ratio 1/2 - 1/3. The growth is highly dependent on cell density. |
Doubling Time | very slow | Cell Number in Vial (cells/1ml) | 2.4 x 10^6 |
Viability at cell freezing (%) | 93.8 | Antibiotics Used | free |
Passage Number | P26 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No. | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB1346 | Cell Name | FLAM-76 |
---|---|---|---|
LOT No. | 08312009 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO) with 20% heat inactivated fetal bovine serum(SIGMA027K03911) and IL-6(10 ng/ml) | Temperature | 37 C |
Cell Density at Seeding | NT | Methods for Passages | dilution |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 5.7x10^6 |
Viability at cell freezing (%) | 92.6 | Antibiotics Used | free |
Passage Number | p22 | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:9,12 D13S317:8,11 D7S820:9,10 D16S539:9 VWA:14,17 TH01:6 AM:X,Y TPOX:8,11 CSF1PO:10,12 |
Adhesion | Exoteric Gene | NT | |
Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB1346 | Cell Name | FLAM-76 |
---|---|---|---|
LOT No. | 08232016 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 20% heat-inactivated fetal bovine serum (FBS; Sigma Cat. # 172012) and 10 ng/mL recombinant human IL-6. | Temperature | 37 C |
Cell Density at Seeding | 1.2 - 10 x 10^5 cells/mL | Methods for Passages | Dilution (suspension culture). Split ratio 1/2 - 1/3. The growth is highly dependent on cell density. |
Doubling Time | very slow | Cell Number in Vial (cells/1ml) | 1.4 x 10^6 |
Viability at cell freezing (%) | 85.4 | Antibiotics Used | free |
Passage Number | P33 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 85.4 | Additional information |